Author

D. Bachurski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Schneider· 1 shared B. Sackey· 1 shared B. Soper· 1 shared C. Pallasch· 1 shared C. von Kaisenberg· 1 shared D. Vorholt· 1 shared E. Bauer· 1 shared E. Izquierdo· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Schneider

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

T-cell development and activation in humanized mice lacking mouse major histocompatibility complexes

M. Darguzyte, P. Amtczak, D. Bachurski, P. Hoelker, N. Abedpour, R. Gholaminpoorfard, H. Schlösser, K. Wennhold, M. Thelen, M. Garcia-Marquez, J. Koenig, A. Schneider, T. Braun, F. Klawonn, M. Damrat, , R. Stripecke

This study shows human T-cell development in humanized mice can occur without mouse MHCs and is enhanced by lentiviral delivery of HLA and cytokines.

bioRxiv · Mar 26, 2024 · PreprintImmunology

Loss of TP53 mediates suppression of Macrophage Effector Function via Extracellular Vesicles and PDL1 towards Resistance against Chemoimmunotherapy in B-cell malignancies

E. Izquierdo, D. Vorholt, B. Sackey, J. Nolte, S. J. Blakemore, J. Schmitz, V. Barbarino, N. Nickel, D. Bachurski, L. Lobastova, M. Nikolic, M. Michalik, R. Brinker, R. Neuhaus, L. Frenzel, , C. Pallasch

This paper identifies that TP53 loss in B-cell lymphoma leads to resistance against chemoimmunotherapy by suppressing macrophage effector function through PDL1-expressing extracellular vesicles.

bioRxiv · Jun 11, 2020 · PreprintCell Biology